An Exploratory Study of Obinutuzumab β in the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Clinical trial NCT07696377 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07696377
Sponsor: Zhongming Qiu
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Obinutuzumab β

Start date: 2026-07-15
Primary completion: 2030-01-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.